Screen4Care

Screen4Care offers an innovative research approach to accelerate rare disease diagnosis, which is based on two central pillars: genetic newborn screening and digital technologies. People living with rare diseases often find themselves on a burdensome diagnosis journey, enduring on average eight years of inconclusive consultations and possible misdiagnoses.
Although rare diseases collectively impact over 30 million people in Europe, most of the individual conditions have a low prevalence. This has resulted in a lack of research and expertise in this field. Diagnosis odysseys and uncertainty around experienced symptoms continue to place a heavy burden on people living with rare diseases, their families, care-takers, doctors and society as a whole.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) and others. Any related content reflect only the views of the project owner.

Visit us at: https://www.screen4care.eu